Cargando…

Basic Mechanisms Mediating Cardiomyopathy and Heart Failure in Aging

Biological aging represents the major risk factor for the development of heart failure (HF), malignancies, and neurodegenerative diseases. While risk factors such as lifestyle patterns, genetic traits, blood lipid levels, and diabetes can contribute to its development, advancing age remains the most...

Descripción completa

Detalles Bibliográficos
Autor principal:	Marín-García, José
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2009
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121883/ http://dx.doi.org/10.1007/978-1-60761-147-9_16

Ejemplares similares

Heart Failure and Cardiomyopathies: CT and MR from Basics to Advanced Imaging
por: Palumbo, Pierpaolo, et al.
Publicado: (2022)

Therapeutic Applications of Cannabinoids in Cardiomyopathy and Heart Failure
por: Garza-Cervantes, J. A., et al.
Publicado: (2020)

The Pathophysiology of Heart Failure in Children: The Basics
por: Knudson, Jarrod D., et al.
Publicado: (2016)

Heart Failure in Patients with Arrhythmogenic Cardiomyopathy
por: Chen, Shi, et al.
Publicado: (2021)

Mechanisms responsible for increased circulating levels of galectin-3 in cardiomyopathy and heart failure
por: Nguyen, My-Nhan, et al.
Publicado: (2018)

Heart failure in dilated non-ischaemic cardiomyopathy
por: Seferović, Petar M, et al.
Publicado: (2019)

Chagas Cardiomyopathy: From Romaña Sign to Heart Failure and Sudden Cardiac Death
por: Pino-Marín, Antonia, et al.
Publicado: (2021)

Severe heart failure due to peripartum cardiomyopathy
por: Michimata, Haruhiko, et al.
Publicado: (2023)

Immunoadsorption Therapy for Patients with Dilated Cardiomyopathy and Heart Failure
por: Ikeda, Uichi, et al.
Publicado: (2008)

Comparison of myocardial mechanical properties in patients with dilated cardiomyopathy with and without acute heart failure
por: Choudhary, Naila, et al.
Publicado: (2014)

Clinical phenotypes and prognosis of thyrotoxic heart failure and cardiomyopathy in patients hospitalized for acute heart failure
por: Kositanurit, Weerapat, et al.
Publicado: (2021)

Cell Cycle Re-Entry and Mitochondrial Defects in Myc-Mediated Hypertrophic Cardiomyopathy and Heart Failure
por: Lee, Hyoung-gon, et al.
Publicado: (2009)

Clinicopathological profiles of progressive heart failure in hypertrophic cardiomyopathy
por: Melacini, Paola, et al.
Publicado: (2010)

Genetics and genomics of dilated cardiomyopathy and systolic heart failure
por: Tayal, Upasana, et al.
Publicado: (2017)

Predicting Heart Failure in Arrhythmogenic Right Ventricular Cardiomyopathy
por: Hylind, Robyn J., et al.
Publicado: (2020)

Genetics of Cardiomyopathy: Clinical and Mechanistic Implications for Heart Failure
por: Kim, Kyung-Hee, et al.
Publicado: (2021)

Testosterone, cardiomyopathies, and heart failure: a narrative review
por: Diaconu, Rodica, et al.
Publicado: (2021)

Cardiac Organoids to Model and Heal Heart Failure and Cardiomyopathies
por: Seguret, Magali, et al.
Publicado: (2021)

Reversible heart failure in a patient with hypocalcemic cardiomyopathy
por: Jafari Fesharaki, Mehrdad, et al.
Publicado: (2021)

Predicting Heart Failure in Arrhythmogenic Right Ventricular Cardiomyopathy
por: Wang, Weijia, et al.
Publicado: (2022)

Diabetes outcomes in heart failure patients with hypertrophic cardiomyopathy
por: Mekhaimar, Menatalla, et al.
Publicado: (2022)

Dilated cardiomyopathy-mediated heart failure induces a unique skeletal muscle myopathy with inflammation
por: Song, Taejeong, et al.
Publicado: (2019)

Elevated resting heart rate in adolescent men and risk of heart failure and cardiomyopathy
por: Lindgren, Martin, et al.
Publicado: (2020)

Survival benefit of ghrelin in the heart failure due to dilated cardiomyopathy
por: Du, Cheng-Kun, et al.
Publicado: (2014)

Biomarkers in Cardiology – Part 1 – In Heart Failure and Specific Cardiomyopathies
Publicado: (2014)

Heart Failure Phenotypes Induced by Knockdown of DAPIT in Zebrafish: A New Insight into Mechanism of Dilated Cardiomyopathy
por: Nagata, Yoji, et al.
Publicado: (2017)

Editorial: Diabetes and heart failure: basic, translational, and clinical research
por: Metzinger, Laurent, et al.
Publicado: (2023)

Bmi1 limits dilated cardiomyopathy and heart failure by inhibiting cardiac senescence
por: Gonzalez-Valdes, I., et al.
Publicado: (2015)

Ceruloplasmin and the Extent of Heart Failure in Ischemic and Nonischemic Cardiomyopathy Patients
por: Xu, Yifei, et al.
Publicado: (2013)

Chloroquine‐induced cardiomyopathy: a reversible cause of heart failure
por: Yogasundaram, Haran, et al.
Publicado: (2018)

Myocyte [Na(+)](i) Dysregulation in Heart Failure and Diabetic Cardiomyopathy
por: Despa, Sanda
Publicado: (2018)

Can the onset of heart failure be delayed by treating diabetic cardiomyopathy?
por: Marcinkiewicz, Anna, et al.
Publicado: (2017)

Myosin modulators: emerging approaches for the treatment of cardiomyopathies and heart failure
por: Day, Sharlene M., et al.
Publicado: (2022)

Genetic predisposition study of heart failure and its association with cardiomyopathy
por: Kaviarasan, Vaishak, et al.
Publicado: (2022)

Machine Learning for Predicting Heart Failure Progression in Hypertrophic Cardiomyopathy
por: Fahmy, Ahmed S., et al.
Publicado: (2021)

Maintaining Success for Patients With Dilated Cardiomyopathy and Remission of Heart Failure
por: Halliday, Brian P., et al.
Publicado: (2022)

Ischemic Cardiomyopathy and Heart Failure After Acute Myocardial Infarction
por: Del Buono, Marco Giuseppe, et al.
Publicado: (2022)

Human Immunodeficiency Virus Infection-Associated Cardiomyopathy and Heart Failure
por: Papamanoli, Aikaterini, et al.
Publicado: (2022)

A Long Road to Personalized Medicine in Heart Failure and Cardiomyopathies
por: Nagatomo, Yuji
Publicado: (2023)

LONG TERM SIDE EFFECTS OF HYDROXYCHLOROQUINE: CARDIOMYOPATHY AND HEART FAILURE
por: Walton, John, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qdcfmjrls8uvbh132b9rqsebck